IFNA1 and major depressive disorder: This study aimed to develop a non-human primate model using long-term intracerebroventricular (i.c.v.)administration of IFN-α (5 days/week for 6 weeks), to observe the induced depressive-like behaviors and to explore the contributions of monoamine neurotransmitter systems in the development of depression.